Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema. - Wikidata - awgldk - TriplyDB

Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema.

Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema.

http://www.wikidata.org/entity/Q33855641

about

Combined pulmonary fibrosis and emphysema syndrome: a review Therapeutic Approach to Adult Fibrotic Lung Diseases Managing comorbidities in idiopathic pulmonary fibrosis Coaching patients during pulmonary function testing: A practical guide Combined pulmonary fibrosis and emphysema (CPFE): what radiologist should know.Combined pulmonary fibrosis and emphysema: an increasingly recognized condition.Idiopathic pulmonary fibrosis: new insights on functional characteristics at diagnosis.The value of CT for disease detection and prognosis determination in combined pulmonary fibrosis and emphysema (CPFE).Combined pulmonary fibrosis and emphysema.Wnt coreceptor Lrp5 is a driver of idiopathic pulmonary fibrosis.Clinical case: Combined pulmonary fibrosis and emphysema with pulmonary hypertension--clinical management.Clinical relevance of plasma prostaglandin F2α metabolite concentrations in patients with idiopathic pulmonary fibrosis.Rheumatoid arthritis-associated interstitial lung disease: diagnostic dilemma Combined pulmonary fibrosis and emphysema (CPFE): an entity different from emphysema or pulmonary fibrosis alone.Prognosis of nonspecific interstitial pneumonia correlates with perivascular CD4+ T lymphocyte infiltration of the lung.Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE)Combined pulmonary fibrosis and emphysema: a retrospective analysis of clinical characteristics, treatment and prognosis.Visually stratified CT honeycombing as a survival predictor in combined pulmonary fibrosis and emphysema Adiponectin inhibits Wnt co-receptor, Lrp6, phosphorylation and β-catenin signaling.Diagnosis and management of interstitial lung disease.Managing Idiopathic Pulmonary Fibrosis: Which Drug for Which Patient?Effect of Emphysema Extent on Serial Lung Function in Patients with Idiopathic Pulmonary Fibrosis.The Preoperative Composite Physiologic Index May Predict Mortality in Lung Cancer Patients with Combined Pulmonary Fibrosis and Emphysema.Newer developments in idiopathic pulmonary fibrosis in the era of anti-fibrotic medications.Impact of combined pulmonary fibrosis and emphysema on surgical complications and long-term survival in patients undergoing surgery for non-small-cell lung cancer Understanding COPD-overlap syndromes.Severe pulmonary hypertension due to combined pulmonary fibrosis and emphysema: another cause of death among smokers.Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis.Clinical efficacy and safety of ICS/LABA in patients with combined idiopathic pulmonary fibrosis and emphysema Pulmonary fibrosis and emphysema: Is the emphysema type associated with the pattern of fibrosis?Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease.Annual Change in Pulmonary Function and Clinical Characteristics of Combined Pulmonary Fibrosis and Emphysema and Idiopathic Pulmonary Fibrosis: Over a 3-Year Follow-up.Pulmonary hypertension and systemic sclerosis: the role of high-resolution computed tomography.Comparison of clinical characteristics and prognostic factors of combined pulmonary fibrosis and emphysema versus idiopathic pulmonary fibrosis alone.Emphysema and pulmonary fibrosis: coincidence or conspiracy?Thin-section computed tomography-determined usual interstitial pneumonia pattern affects the decision-making process for resection in newly diagnosed lung cancer patients: a retrospective study.Assessing the Therapeutic Response to Pirfenidone in Idiopathic Pulmonary Fibrosis: Can We Do Better than with Forced Vital Capacity Alone?Clinical characteristics and outcomes of lung cancer patients with combined pulmonary fibrosis and emphysema: a systematic review and meta-analysis of 13 studies.Extracellular matrix in lung development, homeostasis and disease.The prognostic impact of combined pulmonary fibrosis and emphysema in patients with clinical stage IA non-small cell lung cancer.

P2860

Q24614740-F35B80B6-E2FB-4CEC-B25C-99E7FFA21D5C Q26741569-89E000C1-84B0-466A-86FA-5EC1D1564BFE Q26785617-8A49387B-BA61-47C3-8572-63AE4A2A3BAC Q26797422-0D0C3C3F-859A-457E-B788-590CE53FF69F Q30251899-9868F894-13F3-4B50-BA4E-6386B769CA03 Q33942950-2CD9AB93-75B7-4AA5-97A3-9B0EFE535C57 Q34026607-A706FA32-56BF-484D-A505-04B8CF44D06F Q34156210-E14BE9B6-8E79-4264-ABCA-6FE4027BA478 Q34325239-A6406BB2-A2FC-4D88-B727-29F817DD2169 Q34480454-485BDC88-4CFF-4D86-9019-F9C55C0F1010 Q34756421-EC374E4D-4882-4583-B88D-A9FBB0216E98 Q34776159-F0C39B8D-5E56-4B36-9647-8CCDBC927BBA Q35029858-EF61F70D-C0C2-4A21-9AE5-965ACC9B7B63 Q35568385-B4E334AD-819B-44EE-8DFE-D7778AD08A28 Q35819353-A2DE780D-19F0-48FE-BBDB-89B9E9DADF6D Q36060275-ED8C130B-16C1-4EED-AB21-F6AD0A3B3109 Q36181634-F1D1B827-41C2-4797-ADC3-1A1C95C053FA Q36550608-E68D36D9-D6D8-49CE-AE66-3E61BEE89DC0 Q36563098-3937FD70-4FB5-4F6C-A062-2E806BAE950B Q38288028-00D79A2C-50F5-41A6-8BFA-696A23746538 Q38598382-0A916E81-7528-48D4-8015-27592ED0A1E5 Q38705047-AC91654D-ECCD-4C25-A141-670FEB0F25F9 Q38715439-86F891F0-3D35-4BFC-B3E7-87421E3550C7 Q38812037-80C2AF9F-A122-4878-91BC-F7901ED20130 Q38880363-33523E2F-E731-4513-9FD5-A3AC11140E98 Q39173255-25B53B65-9080-4FB1-898A-43B54C7EB223 Q39456087-5AA2FB69-7774-4BE6-ADE9-A3FC80CBF615 Q40234409-940745CB-A127-4119-88F3-BB0B9E8F4805 Q41450264-E3D65A40-6F1F-4C11-B167-999FE099E430 Q41784217-227EE65D-927C-4CC3-A492-7BEE58BE1484 Q42050224-A01BC81B-0479-4474-8BB9-93DA6F598336 Q42247408-91D2BE28-D060-4C3A-836E-8204D3F1B614 Q43754038-0AF696DF-BEDD-400F-BF1E-C1DA77B7951D Q46209938-F377BBD0-666C-485C-A87F-2B3349D3563B Q46658703-AC8C6AD6-19E7-4164-AFE8-003CD283523E Q47204595-07E3114E-8CAF-438B-8C53-9BF1A17324DC Q48218867-60EDA267-1F59-4468-9545-73F250991089 Q49200880-E30678BC-A6AD-440C-B4B8-7A44E2BE58A3 Q50420061-A7EAC116-A905-4C40-850A-92144E306929 Q51804751-C763BA0A-2A5A-4067-83FC-42CFD68DFBA8

P2860

Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema.

http://www.wikidata.org/entity/Q33855641

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Pulmonary function measures pr ...... monary fibrosis and emphysema.

@ast

Pulmonary function measures pr ...... monary fibrosis and emphysema.

@en

type

label

Pulmonary function measures pr ...... monary fibrosis and emphysema.

@ast

Pulmonary function measures pr ...... monary fibrosis and emphysema.

@en

prefLabel

Pulmonary function measures pr ...... monary fibrosis and emphysema.

@ast

Pulmonary function measures pr ...... monary fibrosis and emphysema.

@en

P1433

Q33855641-E50695CD-88EB-4CF9-8FA9-DDD5FC7F0604

P1476

Q33855641-A4225B73-84A6-483E-817E-450E935750FE

P2093

Q33855641-0E67D78F-F345-4EE2-A65D-E1766448B643

Q33855641-128FCA70-247A-4439-9CFE-766D711559FC

Q33855641-4BBC58EC-460A-44CE-85C2-E243EC7FC8A9

Q33855641-5BFA7C33-D03E-45E2-B022-A0AA636F6B3F

Q33855641-5C4A8D61-F71D-493A-A2EB-36564138DB48

Q33855641-A0CC8454-F5C5-487A-B57C-8FAC536E475F

Q33855641-ABDEB736-26F6-4E08-888D-534F0F6D2D1F

Q33855641-C6A46B01-DFB8-4735-9361-9CC0CDEF22D0

Q33855641-C957158A-699B-4E04-A462-6BC7182E06D2

Q33855641-CCDED166-3B83-441D-A067-AA82C00FDFAA

P2860

Q33855641-11FBC422-F2B4-45C9-AA85-36F954D15D85

Q33855641-1AFFEAC3-014F-4BD1-B36F-A1335D46C626

Q33855641-1DF9C6C8-96BF-49C8-9BBD-6A75C1C52EF1

Q33855641-3E2368B3-1B35-430B-A288-5706A7117A54

Q33855641-40B65042-566F-4C89-B8F9-531DC24ABFA9

Q33855641-54161132-CFE3-4A76-B827-1A9C75436866

Q33855641-59B24D85-E469-4C14-A902-52DDB9693EFD

Q33855641-5F4B4439-CC54-4538-9BB0-E892278243A9

Q33855641-7D266F0C-42A1-4A9C-8409-FAB36F2BF220

Q33855641-842B0DC5-FC0A-4EF3-977D-F188F9498D19

P304

Q33855641-000B3E3A-0BA8-4785-AEA3-5B17C77FF2FA

P31

Q33855641-9E30DE1B-1ACB-40D1-AC7A-5FC1E95CF818

P356

Q33855641-FAD15D90-5A67-47C6-B6AB-2F1F9336BB7F

P433

Q33855641-8EF55025-BFC8-421B-9AC1-BA489B5DE0BD

P478

Q33855641-40727F65-697F-4E66-AB59-2FBA94D76C5C

P577

Q33855641-C1CBC8A1-C253-4F73-A635-E939B6BD4642

P698

Q33855641-305B94D7-B30B-48CF-BB35-6B17EBBDCEDF

P921

Q33855641-719D5D3A-2108-4834-8050-A7A977CBA833

P932

Q33855641-576BEA7B-E51B-40A8-A914-76D92194F809

P356

09031936.00114010

P1433

European Respiratory Journal

P1476

Pulmonary function measures pr ...... monary fibrosis and emphysema.

@en

P2093

A Lagstein

http://www.w3.org/2001/XMLSchema#string

A M Nambiar

http://www.w3.org/2001/XMLSchema#string

A R Chughtai

http://www.w3.org/2001/XMLSchema#string

B H Gross

http://www.w3.org/2001/XMLSchema#string

B Sundaram

http://www.w3.org/2001/XMLSchema#string

E A Kazerooni

http://www.w3.org/2001/XMLSchema#string

F J Martinez

http://www.w3.org/2001/XMLSchema#string

G B Toews

http://www.w3.org/2001/XMLSchema#string

J L Myers

http://www.w3.org/2001/XMLSchema#string

K R Flaherty

http://www.w3.org/2001/XMLSchema#string

P2860

Determinants of survival in idiopathic pulmonary fibrosis

The influence of cigarette smoking on lung function in patients with idiopathic pulmonary fibrosis

Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia

American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Soci

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

Demystifying idiopathic interstitial pneumonia.

The clinical course of patients with idiopathic pulmonary fibrosis.

Smoking-related interstitial lung diseases: a concise review.

Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity.

Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis.

P304

176-183

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1183/09031936.00114010

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21148225

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

P932

4084829

http://www.w3.org/2001/XMLSchema#string